Delivery Order SPE2DB22D3004-SPE2DB25FQB61
Award Date
3/27/25
Potential Completion Date
4/17/25
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,816.90, is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,901.40 firm-fixed-price contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $7,633.80 and an ultimate completion date of June 10, 2025. The contract is not set-aside and was awarded on May 19, 2025. AmerisourceBergen Drug Corporation holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a Ceiling Value of $11,410.05, is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a specialty pharmaceutical product. The contract has an Ultimate Completion Date of August 1, 2024 and a Firm Fixed Price pricing type. This award is not designated as a Set-Aside contract. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,820.10 firm fixed-price contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a period of performance through July 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $38,169.00 and a completion date of April 15, 2025. It is a firm fixed-price contract for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
This is a $7,633.80 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a prescription medication. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 7, 2025. No set-aside designation was used for this open competition award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABENUVA ER 400 MG-600 MG SUSP 4ML, a pharmaceutical product, with a ceiling value of $5,078.08 and a period of performance ending on June 10, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,535.20 fixed-price delivery order is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a medication used in the treatment of HIV. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $78,294.60, is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of June 1, 2023. The award was issued on May 10, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...